aMoon

aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.

Category: News

How AI interfaces can help therapists provide better behavioral health care

Posted on October 19, 2021Author gilrabbiCategories News

Eleos Health raises $8M for behavioral health focused AI voice tech

Posted on September 13, 2021September 14, 2021Author gilrabbiCategories News

Rising aMoon and its growing portfolio at the healthcare-tech interface

Posted on September 1, 2021Author gilrabbiCategories News

AI For Population Health And Medical Imaging Gets A Boost With $230 Million Acquisitions

Posted on August 10, 2021December 8, 2021Author gilrabbiCategories News

Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships

Posted on July 23, 2021August 3, 2021Author gilrabbiCategories News

Small activating RNAs lead the charge to turn up gene expression

Posted on July 15, 2021August 3, 2021Author gilrabbiCategories News

MOBILion Systems racks up another $60M to bring faster, smarter mass spectrometry to biopharma

Posted on July 13, 2021August 3, 2021Author gilrabbiCategories News

Eli Lilly adds a $15M equity sweetener for its platform partner in saRNA

Posted on July 6, 2021August 3, 2021Author gilrabbiCategories News

Diets Engineered to Work With Your Microbiome Are Latest Startup Craze

Posted on June 28, 2021June 30, 2021Author gilrabbiCategories News

An Israeli biotech is looking to make its name in the jam-packed CD47 space. Is bifunctionality the answer?

Posted on June 16, 2021August 3, 2021Author gilrabbiCategories News

Posts pagination

Previous page Page 1 … Page 7 Page 8 Page 9 … Page 15 Next page
Contact Careers terms of service privacy policy
aMoon on linkedin aMoon on linkedin aMoon on twitter aMoon on twitter aMoon on youtube aMoon on youtube
Ra'anana, Israel
© aMoon Website by nym. Developed by Rabbi Interactive